Ben Adeyi

2.7k total citations
29 papers, 680 citations indexed

About

Ben Adeyi is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Pharmacology. According to data from OpenAlex, Ben Adeyi has authored 29 papers receiving a total of 680 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Psychiatry and Mental health, 16 papers in Cognitive Neuroscience and 6 papers in Pharmacology. Recurrent topics in Ben Adeyi's work include Attention Deficit Hyperactivity Disorder (24 papers), Bipolar Disorder and Treatment (10 papers) and Functional Brain Connectivity Studies (8 papers). Ben Adeyi is often cited by papers focused on Attention Deficit Hyperactivity Disorder (24 papers), Bipolar Disorder and Treatment (10 papers) and Functional Brain Connectivity Studies (8 papers). Ben Adeyi collaborates with scholars based in United States, Germany and United Kingdom. Ben Adeyi's co-authors include Bryan Dirks, T. Babcock, Robert Lasser, Gail L. Woods, David Coghill, Hedy Teppler, Paul Hodgkins, Alessandro Zuddas, Michel Lecendreux and Tobias Banaschewski and has published in prestigious journals such as PEDIATRICS, BMC Psychiatry and International Journal of Antimicrobial Agents.

In The Last Decade

Ben Adeyi

29 papers receiving 647 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Adeyi United States 17 414 211 111 96 92 29 680
Eloise Lemon United States 6 190 0.5× 59 0.3× 58 0.5× 85 0.9× 163 1.8× 8 408
Akhilesh Sharma India 13 155 0.4× 37 0.2× 73 0.7× 62 0.6× 149 1.6× 49 700
Tatjana Novakovic-Agopian United States 11 86 0.2× 200 0.9× 162 1.5× 17 0.2× 44 0.5× 25 621
Alexandra S. Rooney United States 15 209 0.5× 90 0.4× 211 1.9× 19 0.2× 58 0.6× 35 701
Greta Bushnell United States 12 109 0.3× 33 0.2× 43 0.4× 54 0.6× 97 1.1× 39 600
Roxana Maxim Romania 4 195 0.5× 127 0.6× 89 0.8× 4 0.0× 55 0.6× 6 536
Manijeh Kahbazi Iran 11 89 0.2× 51 0.2× 45 0.4× 20 0.2× 28 0.3× 37 374
Peter Scheer Austria 18 312 0.8× 27 0.1× 57 0.5× 18 0.2× 196 2.1× 62 843
Kenneth D. Hampton United States 10 124 0.3× 49 0.2× 81 0.7× 56 0.6× 25 0.3× 14 387
Martha J. Barthel United States 10 186 0.4× 37 0.2× 64 0.6× 17 0.2× 87 0.9× 17 894

Countries citing papers authored by Ben Adeyi

Since Specialization
Citations

This map shows the geographic impact of Ben Adeyi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Adeyi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Adeyi more than expected).

Fields of papers citing papers by Ben Adeyi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Adeyi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Adeyi. The network helps show where Ben Adeyi may publish in the future.

Co-authorship network of co-authors of Ben Adeyi

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Adeyi. A scholar is included among the top collaborators of Ben Adeyi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Adeyi. Ben Adeyi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Häge, Alexander, Regina Dittmann, Michael Pennick, et al.. (2014). P.7.f.009 Lisdexamfetamine dimesylate: hydrolysis, pharmacokinetics and duration of therapeutic action in children and adolescents with ADHD. European Neuropsychopharmacology. 24. S733–S734. 1 indexed citations
4.
5.
Hodgkins, Paul, Juliana Setyawan, Tobias Banaschewski, et al.. (2013). Health utility scores in children and adolescents with attention-deficit/hyperactivity disorder: response to stimulant treatment. European Child & Adolescent Psychiatry. 22. 2 indexed citations
6.
Dirks, Bryan, et al.. (2013). Treatment Outcomes with Lisdexamfetamine Dimesylate in Children Who Have Attention-Deficit/Hyperactivity Disorder with Emotional Control Impairments. Journal of Child and Adolescent Psychopharmacology. 23(6). 386–393. 8 indexed citations
7.
Findling, Robert L., Ben Adeyi, Bryan Dirks, et al.. (2013). Parent-Reported Executive Function Behaviors and Clinician Ratings of Attention-Deficit/Hyperactivity Disorder Symptoms in Children Treated with Lisdexamfetamine Dimesylate. Journal of Child and Adolescent Psychopharmacology. 23(1). 28–35. 7 indexed citations
8.
Banaschewski, Tobias, César A. Soutullo, Michel Lecendreux, et al.. (2013). The child health and illness profile as a measure of health-related quality of life in stimulant-treated children and adolescents with ADHD.. European Child & Adolescent Psychiatry. 22. 1 indexed citations
9.
Mattingly, Gregory W., Richard H. Weisler, Joel Young, et al.. (2013). Clinical response and symptomatic remission in short- and long-term trials of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder. BMC Psychiatry. 13(1). 39–39. 30 indexed citations
10.
Banaschewski, Tobias, César A. Soutullo, Michel Lecendreux, et al.. (2013). Health-Related Quality of Life and Functional Outcomes from a Randomized, Controlled Study of Lisdexamfetamine Dimesylate in Children and Adolescents with Attention Deficit Hyperactivity Disorder. CNS Drugs. 27(10). 829–840. 51 indexed citations
11.
Jain, Rakesh K., et al.. (2013). Efficacy and Safety of Lisdexamfetamine Dimesylate in Children with Attention-Deficit/Hyperactivity Disorder and Recent Methylphenidate Use. Advances in Therapy. 30(5). 472–486. 6 indexed citations
12.
13.
Jain, Rakesh K., et al.. (2011). Efficacy of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder previously treated with methylphenidate: a post hoc analysis. Child and Adolescent Psychiatry and Mental Health. 5(1). 35–35. 23 indexed citations
14.
Turgay, Atilla, Lawrence Ginsberg, Elias Sarkis, et al.. (2010). Executive Function Deficits in Children with Attention-Deficit/Hyperactivity Disorder and Improvement with Lisdexamfetamine Dimesylate in an Open-Label Study. Journal of Child and Adolescent Psychopharmacology. 20(6). 503–511. 21 indexed citations
15.
Findling, Robert L., Ben Adeyi, Gary Chen, et al.. (2010). Clinical Response and Symptomatic Remission in Children Treated With Lisdexamfetamine Dimesylate for Attention-Deficit/Hyperactivity Disorder. CNS Spectrums. 15(9). 559–568. 10 indexed citations
16.
Ermer, James, Ben Adeyi, & Michael L. Pucci. (2010). Pharmacokinetic Variability of Long-Acting Stimulants in the Treatment of Children and Adults with Attention-Deficit Hyperactivity Disorder. CNS Drugs. 24(12). 1009–1025. 32 indexed citations
17.
Wigal, Sharon B., Scott H. Kollins, Ann Childress, & Ben Adeyi. (2010). Efficacy and tolerability of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: sex and age effects and effect size across the day. Child and Adolescent Psychiatry and Mental Health. 4(1). 32–32. 22 indexed citations
18.
Stratchounski, L., Gail L. Woods, Ben Adeyi, et al.. (2006). Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit. European Journal of Clinical Microbiology & Infectious Diseases. 25(10). 633–641. 41 indexed citations
19.
Roy, Subir, Edith Ángel‐Müller, Mahmoud Ismail, et al.. (2002). Ertapenem Once a Day Versus Piperacillin–Tazobactam Every6 Hours for Treatment of Acute Pelvic Infections:A Prospective, Multicenter, Randomized, Double‐Blind Study. Infectious Diseases in Obstetrics and Gynecology. 11(1). 27–37. 49 indexed citations
20.
Yellin, Albert E., James M. Hassett, Álvaro Fernández-Quilez, et al.. (2002). Ertapenem monotherapy versus combination therapy with ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections in adults. International Journal of Antimicrobial Agents. 20(3). 165–173. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eloise Lemon Breakdown of academic impact, for papers by Akhilesh Sharma Breakdown of academic impact, for papers by Tatjana Novakovic-Agopian Breakdown of academic impact, for papers by Alexandra S. Rooney Breakdown of academic impact, for papers by Greta Bushnell Breakdown of academic impact, for papers by Roxana Maxim Breakdown of academic impact, for papers by Manijeh Kahbazi Breakdown of academic impact, for papers by Peter Scheer Breakdown of academic impact, for papers by Kenneth D. Hampton Breakdown of academic impact, for papers by Martha J. Barthel
Rankless by CCL
2026